YY1 and cancer: The relationship between YY1 mRNA expression and clinicopathological parameters in patients with ESCA was analyzed by UALCAN, based on individual cancer stages, patient's race, nodal metastasis status, patient's age, patient's smoking habits, TP53 mutation status, and tumor histology.